(Q36288956)

13 August 2017

Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling (English)

1 reference

13 August 2017

0 references

Ultan McDermott

1

0 references

Nathanael Gray

23

object named as

Nathanael S Gray

1 reference

13 August 2017

24

Daniel A Haber

1 reference

13 August 2017

16

Shyamala Maheswaran

1 reference

13 August 2017

4

Patricia Greninger

1 reference

13 August 2017

Sreenath V Sharma

2

1 reference

13 August 2017

Lori Dowell

3

1 reference

13 August 2017

Clara Montagut

5

1 reference

13 August 2017

Jennifer Lamb

6

1 reference

13 August 2017

Heidi Archibald

7

1 reference

13 August 2017

Raul Raudales

8

1 reference

13 August 2017

Angela Tam

9

1 reference

13 August 2017

Diana Lee

10

1 reference

13 August 2017

S Michael Rothenberg

11

1 reference

13 August 2017

Jeffrey G Supko

12

1 reference

13 August 2017

Raffaella Sordella

13

1 reference

13 August 2017

Lindsey E Ulkus

14

1 reference

13 August 2017

A John Iafrate

15

1 reference

13 August 2017

Ching Ni Njauw

17

1 reference

13 August 2017

Hensin Tsao

18

1 reference

13 August 2017

Lisa Drew

19

1 reference

13 August 2017

Jeff H Hanke

20

1 reference

13 August 2017

Xiao-Jun Ma

21

1 reference

13 August 2017

Mark G Erlander

22

1 reference

13 August 2017

Jeffrey Settleman

25

1 reference

13 August 2017

language of work or name

English

0 references

publication date

6 December 2007

1 reference

Proceedings of the National Academy of Sciences of the United States of America

13 August 2017

1 reference

13 August 2017

104

1 reference

13 August 2017

19936-19941

1 reference

13 August 2017

50

1 reference

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2148401

Lung cancer cell lines harboring MET gene amplification are dependent on Met for growth and survival

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2148401

Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2148401

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2148401

Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2148401

Where next for gefitinib in patients with lung cancer?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2148401

Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2148401

BRAF mutation predicts sensitivity to MEK inhibition

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2148401

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2148401

Guilty as charged: B-RAF is a human oncogene

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2148401

Cancer. Addiction to oncogenes--the Achilles heal of cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2148401

Mutations of the BRAF gene in human cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2148401

Cluster analysis and display of genome-wide expression patterns

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2148401

Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2148401

Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFR.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2148401

Phase II study of gefitinib in patients with relapsed or persistent ovarian or primary peritoneal carcinoma and evaluation of epidermal growth factor receptor mutations and immunohistochemical expression: a Gynecologic Oncology Group Study

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2148401

Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2148401

Gene amplification in gastric and esophageal adenocarcinomas

22 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18077425

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Gefitinib-sensitizing mutations in esophageal carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18077425

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1073/PNAS.0707498104

1 reference

13 August 2017

0 references

1 reference

13 August 2017

1 reference